Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Biomarkers Summit

Innovations in stratified medicine

16th January to 17th January 2013, London, United Kingdom



SMi’s sixth Annual Biomarkers conference unites advances in biomarker use for drug discovery and development, alongside biomarkers for cancer.  This two-day meeting showcases the best new opportunities and strategies to accelerate go/no-go decision making in early and clinical development.

Key academic, government and industry figures cover topics encompassing:

  • Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors
  • Interactive panel discussion focusing on current developments in personalised medicine via biomarkers
  • Latest advancements in molecular diagnostics and multi-centre clinical imaging studies
  • New developments in pharmacogenetic and pharmacogenomic statistical study design
  • Future direction and initiatives for safety biomarkers
  • Maximise the cost-effectiveness of your companion diagnostic for end-users

Benefits of Attending


Featured Speakers


Who Should Attend